RM
Risankizumab injection for psoriasis
35 year old male patient self injecting using a Risankizumab (trade name Skyrizi) pen. Risankizumab is a humanised monoclonal antibody that binds to interleukin 23A (IL-23A) and blocks the activity of pro-inflammatory cytokines. Risankizumab is used to treat moderate to severe plaque psoriasis and active psoriatic arthritis., by DR P. MARAZZI/SCIENCE PHOTO LIBRARY
Details
ID
185191010
Collection
License type
Rights Managed
Photographer
Model Release
Model release is available
More
Top Categories